Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Synageva BioPharma Corp. (GEVA)

-NasdaqGS
78.90 Down 0.48(0.60%) Apr 17, 4:00PM EDT
|After Hours : 78.90 0.00 (0.00%) Apr 17, 4:29PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 3,474   1,369   3,413   5,118  
Cost of Revenue -   -   -   -  
Gross Profit 3,474   1,369   3,413   5,118  
Operating Expenses
Research Development25,176  22,676  18,454  13,338  
Selling General and Administrative8,866  6,597  6,443  5,654  
Non Recurring -   -   -   -  
Others376  292  706  699  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (30,944) (28,196) (22,190) (14,573)
Income from Continuing Operations
Total Other Income/Expenses Net(86)73  83  89  
Earnings Before Interest And Taxes(30,688)(28,123)(22,107)(14,484)
Interest Expense -   -   -   -  
Income Before Tax(30,688)(28,123)(22,107)(14,484)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(30,736)(28,123)(22,107)(14,484)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (30,736) (28,123) (22,107) (14,484)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (30,736) (28,123) (22,107) (14,484)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.